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Abstract: The literature is uncertain about the extent to which those who attend cardiac rehabilitation
(CR) gain weight while trying to quit smoking. This study aimed to determine the extent of
CR-based smoking cessation provision and whether CR, as delivered in routine practice, is associated
with helping patients quit smoking and avoid weight gain. Data from the UK National Audit of
Cardiac Rehabilitation database, between April 2013 and March 2016, were used. Smoking status is
categorised as smokers and quitters assessed by patient self-report. Outcomes included body weight,
blood pressure, depression, and physical activity. A multiple linear regression model was constructed
to understand the effect of continuing smoking or quitting smoking on CR outcomes. CR outcome
scores were adjusted by the baseline CR score for each characteristic. An e-survey collected
information about the smoking cessation support offered to patients attending CR. A total of
2052 smokers (58.59 ± 10.49 years, 73.6% male) and 1238 quitters (57.63 ± 10.36 years, 75.8% male)
were analysed. Overall, 92.6% of CR programmes in the United Kingdom (UK) offer smoking
cessation support for CR attenders. Quitting smoking during CR was associated with a mean increase
in body weight of 0.4 kg, which is much less than seen in systematic reviews. Quitters who attended
CR also had better improvements in physical activity status and psychosocial health measures
than smokers. As delivered in routine practice, CR programmes in the UK adhere to the guideline
recommendations for smoking cessation interventions, help patients quit smoking, and avoid weight
gain on completion of CR.
Keywords: cardiac rehabilitation; cardiovascular diseases; smoking; weight gain
1. Introduction
Smoking is a risk factor for cardiovascular disease (CVD) and the cause of death for approximately
8 million people annually [1]. For developing non-communicable diseases such as cardiovascular,
cancers, and respiratory diseases, smoking is considered a preventable risk factor [2].
A meta-analysis by Aubin et al. of 62 clinical trials that described weight gain in smokers who
quit smoking for up to 12 months suggests that body weight increased on average by 1.12 kg, 2.26 kg,
2.85 kg, 4.23 kg, and 4.67 kg at one, two, three, six, and 12 months, respectively, after quitting [3].
Most of the weight gain occurs within three months of quitting, and estimates of weight gain were
similar among smokers using different pharmacotherapies to support smoking cessation [3].
A large systematic review and meta-analysis of 35 prospective cohort studies with 63,403 quitters
and 388,432 continuing smokers looking at the association between smoking cessation and weight
gain found that quitting smoking was associated with a mean weight gain of 4.10 kg and mean
body mass index (BMI) gain of 1.14 kg/m2 over an average of 5 years [4]. The participants in this
meta-analysis were similar to the general population in contrast to participants in the meta-analysis
by Aubin et al. [3], making their findings more generalisable. In addition, the cohort studies in the
meta-analysis by Tian et al. [4] had longer follow-up periods than those in the meta-analyses by
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Aubin et al. [3], which allows for an assessment of the effects of quitting smoking on weight change
beyond 12 months.
The cross-sectional studies of the four EUROASPIRE surveys, which took place between 1999
and 2013, investigated characteristics of successful quitters who had been pre-event smokers and
reported a non-smoking status at the time of interview (median 1.2 years [range 0.5 to 3 years]) [5].
They also found that smoking cessation was associated with weight gain [5]. Numerous cohort studies
have shown that people who stop smoking gain weight [6–12].
Gaining weight while stopping smoking can lead to anxiety and depression. Systematic reviews
and meta-analyses found that overweight, obesity, and depression interacted reciprocally and that
overweight and obesity increased the risk for anxiety and depression [13–15].
Cardiac rehabilitation (CR) is a structured, multi-disciplinary intervention that is offered to
patients with CVD with the goal of reducing risk factors (smoking) and promoting psychosocial
wellbeing [16–18]. Positive health outcomes, such as a reduction in cardiovascular mortality and
hospital readmission, have been associated with CR participation [19,20]. In the United Kingdom (UK),
patients with CVD have access to CR programmes. Programme uptake in the UK averages 50% and
is considered one of the highest uptake figures compared to other countries [21]. CR programmes
are delivered to the British Association for Cardiovascular Prevention and Rehabilitation (BACPR)
standards with the goal of reducing cardiovascular risk and promoting quality of life through
coordinated core components of CVD prevention and rehabilitation [17]. Recommendations include
providing smoking cessation support and relapse prevention through lifestyle risk factor management
as one of its core components [17]. On average, 94% of individuals who join CR programmes in the UK
are classified as non-smokers [21]. The average increase in smoking cessation among individuals who
participate in CR is approximately one percent (1.1%) [21].
A key aim of CR and a goal for most patients is to bring the body mass index (BMI) below
<30 kg/m2 [17]. On average, 30% of patients in the UK started CR with a BMI >30 kg/m2 [21].
The contribution of CR to reducing BMI at a national level is low, with an average change of 0.2% in
patients with BMI <30 kg/m2 after CR [21]. This highlights the difficulty in addressing this risk factor.
Additional factors need to be taken into account before drawing conclusions about how well CR
programmes support weight management. Although smoking cessation results in considerable health
improvements, it is often accompanied by weight gain, with patients who are trying to quit smoking
more likely to put on 3–5 kg of weight in the first three months to a year [3]. Although weight gain
does not offset the health benefits of smoking cessation, which far exceed any health risks that may
result from smoking cessation-induced weight gain, it is frequently a source of concern for smokers
planning to quit [7]. This substantial effect may inhibit the reporting of some successful weight loss
programmes. The link between smoking and body weight is closely related and poses significant
challenges for researchers investigating intervention effects in smokers. The most recent Cochrane
review of 24 trials with a total of 7279 adult participants investigated the effectiveness of exercise-based
interventions alone, or combined with a smoking cessation programmes and concluded no significant
effect from adding exercise to smoking cessation [22]. The same authors do state and concludes
that more studies are needed and that future trials may alter these conclusions [22]. Moreover,
new research published in the British Journal of Pharmacology has confirmed that exercise can help
smokers quit smoking and may aid smoking cessation by reducing the severity of smoking withdrawal
symptoms [23]. As weight gain may be a barrier to quitting smoking or a reason to restart smoking,
CR has not been evaluated in relation to weight gain after smoking cessation. As weight gain may be
a barrier against quitting smoking, it is important to investigate smoking cessation support services
provided in CR to help patients quit smoking while maintaining their weight status. Little is known
about how routinely delivered CR programmes support smoking cessation.
This study determines the extent of CR-based smoking cessation provision and whether CR,
as delivered in routine practice, is associated with helping patients quit smoking and avoid weight gain.
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2. Materials and Methods
2.1. Data Source
Individual, patient-level data from the National Audit of Cardiac Rehabilitation (NACR) were
used in the analyses of this study. The NACR, funded by the British Heart Foundation, is a web-based
registry of CR in the UK. Data on patients who are eligible or referred to CR delivery are entered by
practitioners into an electronic patient dataset according to a data dictionary (www.cardiacrehabilitation.
org.uk/nacr/downloads.htm). The NACR team checks data quality from clinical teams who directly
enters data into a secure online system (hosted by NHS Digital) who then provide NACR with
anonymized local programme-level data. The NACR includes details of a patient’s initiating event,
treatment type, risk factors, drugs, patient demographics, and post-CR clinical outcomes. Anonymised
data is collected for a range of clinical indicators for the purposes of audit and research under Section
251 of the NHS Act 2006 [21]. NHS Digital annually reviews data governance and approval for NACR
projects that aim to improve service quality and patient outcomes. Separate approval for this study
in addition to the e-survey project was not required, as it was considered part of the NACR quality
and outcomes process. The Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) guidelines were used for reporting this observational study [24].
2.2. Participants
Participants included in this study were from the research cohort added to the NACR database
between 1 April 2013 and 31 March 2016. Data has been validated and extracted retrospectively
and there were no exclusion criteria. Analyses included patient sociodemographic data and clinical
characteristics of individuals who started a CR programme with both a baseline and follow-up smoking
status assessments.
2.3. Smoking Outcome Measures
Smoking status is assessed via self-reported questionnaires in the NACR database [21]. Pre- and
post-CR smoking status is categorised into one of the following: never smoked, ex-smoker, stopped
smoking since the event, or current smoking. For the purposes of this study, patients were categorised
as continued smokers (defined as current smokers in pre- and post-CR assessments) or quitters (defined
as current smokers in pre- and no smoking status in post-CR assessment).
A range of patient-level variables collected by the NACR primary dataset were used for the
present study. Variables included anthropometric data, physical, and psychosocial health measures.
Anthropometric measures included weight (kg), height (m), body mass index (BMI) (kg/m2), and waist
circumference (cm). Alcohol consumption status was measured using self-reported questionnaires
related to weekly alcohol consumption. Physical activity was self-reported and categorised into
moderate physical activity (150 min/week; yes/no) or vigorous physical activity (75 min/week;
yes/no)) using the Chief Medical Officer’s Physical Activity Questionnaire [25]. Physical activity
recommendations were based on the Department of Health guidelines for 19–64 and 65+ age groups.
The Hospital Anxiety and Depression Scale (HADS), a reliable and well-validated scale, was used to
assess psychosocial health status. Higher HADS scores represent worse symptoms.
2.4. e-Survey
With the knowledge that smoking cessation is a key part of secondary prevention and rehabilitation
and is included in the BACPR core components of lifestyle risk factor management [17], a cross-sectional
11-item e-survey was sent to CR services to explore smoking cessation services provided by CR
programmes in the UK. The sampling frame encompassed the ‘coordinators’ of the 224 CR programmes
in the UK that electronically enter their data into the NACR. Several reminders were sent out via email
over two months. Data collection took place in the summer of 2016 (May 2016–July 2016). The response
rate was 78% (175/224 CR programmes registered in the NACR).
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2.5. Statistical Analysis
All analyses were performed in the IBM Statistical Package for Social Sciences (SPSS) software
statistics Version 24 (New York, NY, USA). A p-value < 0.05 was considered statistically significant.
Percentage or relative change was used to measure the difference in outcome (post-CR) from
baseline (pre-CR) [26,27]. It was calculated by: (percentage change = pre-CR value − post-CR value/
pre-CR value) * 100
Outliers were detected by the median plus or minus 3 times the median absolute deviation
(3 ±MAD) method [28]. Pre-and post-CR values with more than 3 ±MAD percentage change for each
characteristic were eliminated from the analysis.
A multiple linear regression model was constructed to understand the effect of continuing smoking
or quitting smoking on CR outcomes, with adjustments for the outcome CR score by the baseline
CR score for each characteristic. Post-CR outcomes (with respect to baseline) were introduced into
multiple linear regression models (as continuous dependent variables) and tested against smoking
status (a score of 0 was categorised as a smoker, whereas a score of 1 was categorised as a quitter).
We compared and described analyses of CR patients using the original data with analyses of all data
after replacing missing values, which were handled through the expectation maximisation method [29].
Use of expectation maximisation to handle missing data gave similar results to the original analyses.
Commonly used descriptive statistical parameters, including the number of programmes, percentages,
means or medians, and standard deviations, were used to explore the data.
3. Results
3.1. Cohort Characteristics
A total of 49,725 patients had a pre- and post-CR smoking status recorded. Non-smokers
comprised 93.4% of the sample (mean age 65.72 ± 11.08 years, 74.7% male), while 4.1% of the sample
were classified as continued smokers (mean age 58.59 ± 10.49 years, 73.6% male) and 2.5% were quitters
(mean age 57.63 ± 10.36 years, 75.8% male). The median duration of CR was 9 weeks. For the purposes
of this research, patients were categorised as continued smokers or quitters (Table 1).
Table 1. Smoking categorisation groups.




n = Number of patients; % percentage of patients.
3.2. Smokers Versus Quitters (Outcomes)
The CR outcome results between smokers and quitters are summarised in Table 2.
Table 2. Baseline and outcome values for cardiac rehabilitation (CR) patients included in the analysis.
CR Outcome
Smokers Quitters
Pre-CR Post-CR n Pre-CR Post-CR n
Weight (Kg) 81.64 81.68 1499 83.83 84.28 881
BMI (kg/m2) 27.99 28.28 1442 28.01 28.47 833
Waist (cm) 98.47 98.09 657 97.39 97.11 272
Alcohol consumption 17.78 13.80 486 15.66 11.28 298
HADS anxiety score 7.89 7.39 1046 6.92 5.79 546
HADS depression score 6.53 5.68 1032 5.44 4.24 530
BMI, body mass index; CR, cardiac rehabilitation; HADS, hospital anxiety and depression scale; n = number
of patients.
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After controlling for baseline characteristics, predictions were made to determine outcome changes
for patients who quit smoking while attending CR. Only CR patients with pre- and post-CR values
were included in the analysis after excluding pre- and post-values with percentage change more
than 3 ±MAD.
A multiple regression model was constructed to understand the effect of quitting smoking on CR
outcomes with adjustments for the outcome CR score by the baseline CR score for each characteristic
(Table 3). Moreover, post-CR outcomes (with respect to baseline) were introduced into multiple linear
regression models (as continuous dependent variables) and tested against smoking status (score 0 for
smokers; score 1 for quitters).






95% CI Effect Size
B S.E. Beta Sig. Lower Upper
Weight (n = 2380)
Constant 0.75 0.24 <0.001 0.28 1.23
0.01Baseline weight 0.99 0.00 0.99 <0.001 0.99 1.00
Smoking 0.43 0.11 0.01 <0.001 * 0.22 0.63
BMI (n = 2275)
Constant 0.41 0.10 <0.001 0.22 0.61
0.01Baseline BMI 0.99 0.00 0.99 <0.001 0.98 0.99
Smoking 0.18 0.04 0.02 <0.001 * 0.10 0.25
Waist (n = 929)
Constant 4.52 0.75 <0.001 3.05 5.99
0.00Baseline waist 0.95 0.01 0.97 <0.001 0.94 0.97
Smoking 0.05 0.23 0.00 0.83 −0.40 0.49
Alcohol
consumption (784)




0.56 0.02 0.73 <0.001 0.52 0.60
Smoking −1.34 0.68 −0.05 0.05 * −2.68 0.00
HADS anxiety
score (1592)




0.77 0.02 0.76 <0.001 0.74 0.80
smoking −0.75 0.15 −0.08 <0.001 * −1.04 −0.45
HADS depression
score (1562)




0.74 0.02 0.74 <0.001 0.70 0.77
smoking −0.58 0.14 −0.07 <0.001* −0.86 −0.30
B = unstandardised regression coefficient; Beta = standardized coefficient; BMI, body mass index; CI = Confidence
Interval for unstandardised regression coefficient; CR, cardiac rehabilitation; HADS, hospital anxiety and
depression scale; n = Number of patients; S.E. = standard error of the coefficient. * p < 0.05.
A χ2 test was conducted for the association between smokers and quitters and moderate physical
activity (150 min/week) outcomes: improved (n = 679), no change (n = 1126), and worsened (n = 93).
There was a statistically significant association between the smoking group and moderate physical
activity outcomes: χ2(2) = 23.50, p < 0.001, and small association Cramér’s V = 0.11 (Table 4). A χ2 test
was conducted for the association between smokers and quitters and vigorous physical activity
(75 min/week) outcomes: improved (n = 338), no change (n = 1217), and worsened (n = 47). There was
a statistically significant association between smoking status and vigorous physical activity outcomes:
χ
2(2) = 17.88, p < 0.001; small association Cramér’s V = 0.11) (Table 4).
Table 4. Summary of multiple regression analysis.
Physical Activity Outcomes
Smokers (%) Quitters (%)
Improve No Change Worsen Improve No Change Worsen
∆ 150 min/week (moderate) 31.9 62.8 5.4 43 52.9 4.1
∆ 75 min/week (vigorous) 18.0 79.3 2.6 26.6 70.0 3.5
∆, change; % percentage.
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3.3. e-Survey
Overall, 175 CR programmes participated—a response rate of 78% (175/224 CR programmes
registered in the NACR). The following results present an overview of the survey results (Figure 1).
Figure 1. Number of cardiac rehabilitation programmes providing stopping smoking support.
CR: cardiac rehabilitation; Internal: delivering the smoking cessation support services at the CR
programme site; External: external referral.
Most CR programmes in the UK offered smoking cessation support for CR attenders: 162 (92.6%)
programmes, while 13 (7.4%) of CR programmes did not provide patients with support to stop smoking.
About half of CR programmes (87 (49.7%) programmes) offered both internal and external smoking
cessation support for CR attenders. Six CR programmes only offered internal support, by delivering
smoking cessation support services at the CR programme sites, while 69 (39.4%) CR programmes only
offered external referrals.
Notably, 72/93 (77.4%) CR programmes that delivered smoking cessation support at the CR
programme sites (internal delivery: 6 only internal + 87 both = 93 internal) offered one-to-one
sessions. On the other hand, 41 (44.1%) CR programmes offered group education support as a form of
internal support.
Eighty four (90.3%) CR programmes that offered smoking cessation support delivered it internally
through the CR team. On the other hand, 30 (32.3%) CR programmes delivered smoking cessation
support through other qualified staffmembers.
Sixty (38.5%) CR programmes that offered external support for smoking cessation (external
delivery: 69 only external + 87 both = 156 external) offered referrals to doctors or general practitioners
and 133/156 (85.3%) CR programmes offered referrals to community-based cessation programmes.
For 73/162 (45.1%) CR programmes that offered smoking cessation support, patient preference
was the most frequently cited factor for whether a patient attended an internal CR programme’s
smoking cessation service or was referred to external support (Table 5). However, eight (4.9%) CR
programmes cited availability as a factor that influenced whether a patient would receive internal or
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external support; one (0.6%) reported funding constraints, and 36 (22.2%) CR programmes reported
specific patient needs (e.g., hardened smoker).
Table 5. What might decide whether a patient would attend the CR Programme or be referred out?
Reason n = 162 Percentage (%)
Availability 8 4.9
Patient preference 73 45.1
Service funding constraints 1 0.6
Specific patient needs 36 22.2
n = Number of programmes; % percentage of programmes.
Funding was the most common factor for not providing support for smoking cessation for CR
attenders, given as the reason by 12/13 (92.3%) CR programmes that did not provide support for patients
to stop smoking. The other factor reported by only one CR programme was lack of appropriate staff.
4. Discussion
Our research findings show that, after CR, quitters, on average, gain 0.43 kg more than those
who continue to smoke (p < 0.001) and have a BMI of 0.18 kg/m2 more than those who continue
to smoke (p < 0.001). Although differences in weight and BMI scores after CR were statistically
significantly different for quitters and continued smokers (driven by a large sample size of 49,725),
the mean differences of 0.43 kg and 0.18 kg/m2 were very small from a clinical perspective and
much lower than previously cited reviews of smoking cessation where the mean weight gain was
around 4 kg [3–5]. The lack of clinically relevant differences in this data are sufficient to make a strong
clinical recommendation regarding the impact of CR to prevent weight gain when delivered alongside
smoking cessation in patients with heart disease. Our study shows no clinically significant weight gain
in the short term.
Evidence suggests that quitting smoking is associated with a mean increase in body weight
of 3–5 kg, with most weight gain occurring within 3 months of quitting [3–5]; however, the research
findings reported here show that smokers who quit smoking while attending CR do not gain weight,
which aligns with the findings of Farley et al. that exercise could reduce post-cessation weight gain [30].
With regard to smoking and weight interactions, the extent of weight gain associated with smoking
cessation in patients attending CR is much less than previous studies suggest. These research findings
provide evidence that CR is positively associated with weight management during smoking cessation.
The confidence interval for mean difference in weight between continued smokers and quitters
after CR was 0.22 to 0.63 kg and for mean difference in BMI, it was 0.1 to 0.25 kg/m2. Because of the
well-documented health benefits of quitting smoking, clinicians should inform smokers about the low
likelihood of weight gain and encourage them to attend CR to avoid excess weight gain.
There is no clinical trial evidence for the effectiveness of smoking cessation interventions within CR;
however, our research findings suggest CR as delivered in routine practice is associated with helping
patients quit smoking and reduce the likelihood of weight gain beyond 1 kg. The NACR data regarding
smoking status suggest that about 37.6% of patients who are smoking when recruited to CR successfully
stop after CR. Quitting smoking is considered a core element in both primary and secondary prevention
of cardiovascular disease [31].
Following CR, quitters on average drink 1.34 units of alcohol fewer than those who continue
to smoke. Following CR, 43% and 26.6% of quitters improved to achieve the recommended UK
moderate and vigorous physical activity guidelines, respectively, compared with 31.9% and 18% of
continued smokers. An even stronger benefit was seen in both HADS anxiety and depression scores,
which showed that quitters on average score 0.75 and 0.58 less anxious and less depressed than those
who continue to smoke.
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Our survey of smoking cessation support services, offered in routine practice to CR attenders,
had a high response rate of 78%. Although one study has shown low levels of cessation support
following hospital discharge [32], the e-survey showed that 92.6% of CR programmes in the UK offer
smoking cessation support for patients attending CR. These results show that CR programmes in the
UK adhere to guideline recommendations for smoking cessation interventions [17,33–35]. In addition,
the research results suggest that CR programmes in the UK offer assistance for patients who smoke by
delivering smoking cessation support at the CR programme site in the form of individualised one-to-one
sessions or group educational sessions, as well as referral for external smoking cessation support.
The internal support is provided by the CR team or another qualified member of staff. One-to-one
sessions are the dominant service offered at the site of CR programmes, while external provision is
predominantly through referral to community-based cessation programmes. Patient preference is the
factor that most influences whether a patient would attend the CR programme (internal) or be referred
out (external).
Provision of smoking cessation support in CR could have multiple benefits: the presence of such
a programme could entice more smokers to attend CR, and the increased support for cessation they
receive could encourage them to remain in the CR programme generally. Prior studies suggest that CR
attendance improves smoking cessation rates, and Riley et al. found a strong relationship between
smoking cessation and CR attendance [36].
Failure of adherence to guideline recommendations to provide support for smoking cessation for
CR attenders was predominantly due to funding challenges. Cutting funds to CR services is a false
economy, as evidence shows that smoking cessation services provide effective support for smokers
who want to quit [37] and the lack of this provision leads to higher costs for the NHS to manage
and treat diseases caused by smoking in the long term. The National Institute for Health and Care
Excellence (NICE) estimates that for every pound invested in smoking cessation, £2.37 in benefits are
generated [38]. Moreover, the lack of investment in CR programmes may impact on service provision.
In Yorkshire, for example, a qualitative study found staff to be aware of limited service availability [39],
which may influence which patients are invited. Finally, it should not have to be a choice that some
smokers attending CR are supported to quit and others are not.
Comprehensive CR programmes seem to have a beneficial role in helping patients after a cardiac
event or procedure, with significant improvements in smoking behaviour, weight management,
physical activity levels, psychosocial health, and alcohol consumption. When a comprehensive CR
includes exercise with smoking cessation and patient education, this research initiates evidence for
improvements in cardiac risk factors, particularly increased smoking cessation and improvements in
physical and psychosocial health.
Several limitations of our study must be noted. First, the retrospective observational study design
is limited in capturing data and data quality from CR programmes. An 18% gap in data capture
was identified due to some programmes not providing their data electronically. Approximately
31% of patients who began a CR programme did not have post-program data available, affecting
data quality. Non-completion of the program leads to missingness in patient records that may affect
the representativeness of our sample. Self-reported data poses a limitation in terms of determining
smoking status and immediate post-CR analysis. Using self-reported data to determine smoking status
might be subject to recall and social desirability biases. The self-reported smoking status was not
validated with a biochemical marker. Some possible factors that influenced quitting smoking have
been missed from the analysis due to high levels of missing data or may not have been collected
in the NACR. Some smoking cessation drugs in addition to the intensity of the smoking cessation
program (number and duration of the visits) may have affected the considered outcomes and they
are not included as a confounder in the analyses for the outcomes related to smoking cessation and
weight gain [40–42]. However, the strengths of our study include utilizing a prospective cohort design
and an observational approach, and using data from a large-scale dataset that collects routine clinical
information from CR programmes in the UK. This study also suggested that clinical and research
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efforts should be directed towards improving the rate of smoking cessation in patients with CVD by
accounting for factors that predict quitting smoking among CR attendees [43].
5. Conclusions
Cardiac rehabilitation is an effective intervention to manage weight gain when quitting smoking.
Quitting smoking during CR is associated with a mean increase of 0.4 kg in body weight following CR.
Quitters who attended CR improved their physical activity status and psychosocial health measures
compared with smokers.
This research is the first to evaluate smoking cessation support in CR services in the UK,
with 92.6% of CR programmes in the UK offering smoking cessation support for CR attenders.
These results demonstrate adherence of CR in the UK to the guideline recommendations for smoking
cessation interventions.
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